Evolent Health, Inc. - Class A Shares (EVH) Technical Analysis
$10.78▲3.16%
Market is closed - opens 7 PM, 09 May 2025
Insights
- Evolent Health - Class A Shares is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
- Based on analysis of the Oscillators technical indicator, the current market trend for Evolent Health - Class A Shares stock suggests that it is a good time to sell or bad time to initiate a fresh position
- Based on analysis of the Moving Averages technical indicator, Evolent Health - Class A Shares stock is in a uptrend ↗️
- Based on analysis of the Pivot Points, the current market trend for Evolent Health - Class A Shares stock suggests that it is a good time to buy
Analysis Summary
Oscillators
Sell
Neutral
Buy
Moving Averages
Sell
Neutral
Buy
Pivots
Sell
Neutral
Buy
Oscillators
Name | Value | Action |
|---|---|---|
Relative Strength Index | 64.69 | Sell |
Stochastic | 92.97, 83.28 | Neutral |
Ultimate Oscillator | 58.11 | Neutral |
Stochastic Relative Strength Index | 87.3, 88.24 | Sell |
Moving Average Convergence Divergence | 0.26, 0.1 | Buy |
Moving Averages
Simple Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 10.08 | Buy |
20 | 9.66 | Buy |
50 | 9.56 | Sell |
Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 10.18 | Buy |
20 | 9.9 | Buy |
50 | 9.81 | Sell |
Volume Weighted Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 9.99 | Buy |
20 | 9.62 | Buy |
50 | 9.46 | Buy |
Double Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 10.59 | Buy |
20 | 10.19 | Buy |
50 | 9.65 | Buy |
Triple Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 10.8 | Buy |
20 | 10.48 | Buy |
50 | 9.87 | Buy |
Pivot
Pivot | Value |
|---|---|
Resistance L3 | 10.81 |
Resistance L2 | 10.7 |
Resistance L1 | 10.58 |
Pivot Point | 10.47 |
Support L1 | 10.34 |
Support L2 | 10.23 |
Support L3 | 10.11 |
*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.